8 questions to test your outpatient expansion strategy before you invest

8 questions to test your outpatient expansion strategy before you invest Outpatient growth decisions carry long-term implications for access, capital, and sustainability. Use these eight questions to challenge assumptions, clarify trade-offs, and ensure your expansion strategy reflects real market demand. Outpatient expansion is one of the most complex and high-risk growth decisions healthcare leaders face….

Read Full News

China Market Access After NRDL Maturity: What Comes After the Price Reset?

China Market Access After NRDL Maturity: What Comes After the Price Reset? Gaining inclusion in China’s National Reimbursement Drug List (NRDL) is no longer the final victory for Western pharmaceutical companies; it is just the beginning. Securing a spot on the list does not guarantee immediate hospital uptake, nor does it automatically eliminate patient affordability…

Read Full News